TBI-301

N/A

Report date: 2023/02/18 19:35:44

Base Information

Drug NameTBI-301
Drug Alias NameTBI 301TBI-301
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRNA inhibitors
TargetsRibonucleic Acid
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHemosol Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesHemosol Biopharma
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A